Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation
- 1 December 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (12) , 2267-2275
- https://doi.org/10.1038/sj.leu.2401961
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 17 references indexed in Scilit:
- Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periodsBritish Journal of Haematology, 2000
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non‐high‐risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996Acta Paediatrica, 1998
- Impact of Morning Versus Evening Schedule for Oral Methotrexate and 6-Mercaptopurine on Relapse Risk for Children with Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 1997
- Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemiaThe Lancet, 1994
- A Population‐Based Study of Children with Standard Risk Acute Lymphoblastic Leukemia in the Five Nordic CountriesActa Paediatrica, 1989
- A Population‐Based Study of Childhood Acute Lymphoblastic Leukemia Diagnosed from July 1981 through June 1985 in the Five Nordic CountriesActa Paediatrica, 1987
- Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: A pilot study from April 1981Medical and Pediatric Oncology, 1986
- Recent advances in the management of acute lymphocytic leukemiaEuropean Paediatric Haematology and Oncology, 1984
- INTERMEDIATE DOSE METHOTREXATE (IDM) IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA IN NORWAYActa Paediatrica, 1981